North Carolina Eastern Bankruptcy Court

Case number: 5:21-bk-02075 - Falcon Therapeutics, Inc. - North Carolina Eastern Bankruptcy Court

Case Information
Case title
Falcon Therapeutics, Inc.
Chapter
7
Judge
David M. Warren
Filed
09/15/2021
Last Filing
02/06/2023
Asset
No
Vol
v
Docket Header

DeBN




U.S. Bankruptcy Court
Eastern District of North Carolina
RALEIGH DIVISION
Bankruptcy Petition #: 21-02075-5-DMW

Assigned to: Judge David M. Warren
Chapter 7
Voluntary
No asset

Date filed:  09/15/2021
341 meeting:  10/20/2021
Deadline for objecting to discharge:  12/20/2021

Debtor

Falcon Therapeutics, Inc.

701 Corporate Center Drive
Suite 250
Raleigh, NC 27607
DURHAM-NC
Tax ID / EIN: 47-4454466

represented by
Jason L. Hendren

Hendren Redwine & Malone, PLLC
4600 Marriott Drive, Suite 150
Raleigh, NC 27612
919 573-1422
Fax : 919 420-0475
Email: [email protected]

Rebecca F. Redwine

Hendren Redwine & Malone, PLLC
4600 Marriott Drive, Suite 150
Raleigh, NC 27612
919 420-0941
Fax : 919 420-0475
Email: [email protected]

Trustee

Kevin Sink

The Law Office of Kevin L. Sink, PLLC
3700 Glenwood Avenue
Suite 500
Raleigh, NC 27612
919-589-7985
 
 

Latest Dockets
Date Filed#Docket Text
09/15/20214Docket Text
Meeting of Creditors With 341(a) Meeting To Be Held On 10/20/2021 At 09:30 AM At Telephone Conference for Chapter 7 and 12 341 Meet. Last day to file complaint is 12/20/2021. (Scheduled Automatic Assignment, shared account) (Entered: 09/15/2021)
09/15/2021Docket Text
Receipt Of Filing Fee For Voluntary Petition (Chapter 7)( 21-02075-5) [misc,volp7] ( 338.00), Receipt Number A16382810, Amount $ 338.00. (U.S. Treasury) (Entered: 09/15/2021)
09/15/20213Docket Text
Corporate Resolution filed by Jason L. Hendren on behalf of Falcon Therapeutics, Inc.. (Hendren, Jason) (Entered: 09/15/2021)
09/15/20212Docket Text
Request to Activate Debtor Electronic Notice filed by Rebecca F. Redwine on behalf of Falcon Therapeutics, Inc.. (Redwine, Rebecca) (Entered: 09/15/2021)
09/15/20211Docket Text
Chapter 7 Voluntary Petition filed by Falcon Therapeutics, Inc. (Redwine, Rebecca) (Entered: 09/15/2021)